To comply with applicable regulation in Denmark, product-related media releases are removed from our website within three weeks of publication. They are available upon request. Please contact us here. News Category AllArticles of AssociationCompany AnnouncementsMedia Releases Year All202420232022202120202019 Jun 05, 2024 at 6:51 PM CEST Genmab to Participate in a Fireside Chat at the Goldman Sachs 45th Annual Global Healthcare Conference Download Jun 03, 2024 at 3:09 PM CEST Transactions in Connection with Share Buy-back Program Download Download Jun 03, 2024 at 3:00 PM CEST Investigational Tisotumab Vedotin Phase 2 Data Demonstrates Encouraging Antitumor Activity in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC) Download Jun 02, 2024 at 11:30 PM CEST Preliminary Analysis of Data Evaluating Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Demonstrates 95% Overall Response Rate in Patients with Previously Untreated Follicular Lymphoma Download Jun 01, 2024 at 4:00 PM CEST Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC) Download May 27, 2024 at 4:17 PM CEST Transactions in Connection with Share Buy-back Program Download Download May 23, 2024 at 11:00 PM CEST Genmab to Showcase Data in Various Patient Populations to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting Download May 21, 2024 at 5:06 PM CEST Genmab Completes Acquisition of ProfoundBio Download May 21, 2024 at 1:20 PM CEST Transactions in Connection with Share Buy-back Program Download Download May 14, 2024 at 4:02 PM CEST Genmab to Present New and Updated Results From Multiple Clinical Trials Evaluating Epcoritamab Across Various B-Cell Malignancies at the 2024 European Hematology Association (EHA) Congress Download May 13, 2024 at 4:09 PM CEST Transactions in Connection with Share Buy-back Program Download Download May 08, 2024 at 6:19 PM CEST Genmab A/S has published its Articles of Association Download May 07, 2024 at 8:28 PM CEST Capital Increase in Genmab as a Result of Employee Warrant Exercise Download May 06, 2024 at 4:02 PM CEST Transactions in Connection with Share Buy-back Program Download Download May 02, 2024 at 5:02 PM CEST Genmab Announces Financial Results for the First Quarter of 2024 Download Apr 30, 2024 at 12:40 AM CEST TIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical Cancer Apr 29, 2024 at 10:24 AM CEST Transactions in Connection with Share Buy-back Program Genmab Download Download Apr 22, 2024 at 9:30 AM CEST Transactions in Connection with Share Buy-back Program Genmab Download Download Apr 16, 2024 at 12:24 PM CEST Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2024 Download Apr 15, 2024 at 10:08 AM CEST Transactions in Connection with Share Buy-back Program Genmab Download Download Apr 08, 2024 at 11:44 AM CEST Transactions in Connection with Share Buy-back Program Download Download Apr 03, 2024 at 7:34 AM CEST Genmab to Broaden and Strengthen Oncology Portfolio with Acquisition of ProfoundBio Download Apr 02, 2024 at 9:24 AM CEST Transactions in Connection with Share Buy-back Program Download Download Mar 25, 2024 at 2:31 PM CET Transactions in Connection with Share Buy-back Program Download Download Mar 21, 2024 at 7:26 PM CET Genmab A/S has published its Articles of Association Download
Jun 05, 2024 at 6:51 PM CEST Genmab to Participate in a Fireside Chat at the Goldman Sachs 45th Annual Global Healthcare Conference Download
Jun 03, 2024 at 3:09 PM CEST Transactions in Connection with Share Buy-back Program Download Download
Jun 03, 2024 at 3:00 PM CEST Investigational Tisotumab Vedotin Phase 2 Data Demonstrates Encouraging Antitumor Activity in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC) Download
Jun 02, 2024 at 11:30 PM CEST Preliminary Analysis of Data Evaluating Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Demonstrates 95% Overall Response Rate in Patients with Previously Untreated Follicular Lymphoma Download
Jun 01, 2024 at 4:00 PM CEST Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC) Download
May 27, 2024 at 4:17 PM CEST Transactions in Connection with Share Buy-back Program Download Download
May 23, 2024 at 11:00 PM CEST Genmab to Showcase Data in Various Patient Populations to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting Download
May 21, 2024 at 1:20 PM CEST Transactions in Connection with Share Buy-back Program Download Download
May 14, 2024 at 4:02 PM CEST Genmab to Present New and Updated Results From Multiple Clinical Trials Evaluating Epcoritamab Across Various B-Cell Malignancies at the 2024 European Hematology Association (EHA) Congress Download
May 13, 2024 at 4:09 PM CEST Transactions in Connection with Share Buy-back Program Download Download
May 07, 2024 at 8:28 PM CEST Capital Increase in Genmab as a Result of Employee Warrant Exercise Download
May 06, 2024 at 4:02 PM CEST Transactions in Connection with Share Buy-back Program Download Download
May 02, 2024 at 5:02 PM CEST Genmab Announces Financial Results for the First Quarter of 2024 Download
Apr 30, 2024 at 12:40 AM CEST TIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical Cancer
Apr 29, 2024 at 10:24 AM CEST Transactions in Connection with Share Buy-back Program Genmab Download Download
Apr 22, 2024 at 9:30 AM CEST Transactions in Connection with Share Buy-back Program Genmab Download Download
Apr 16, 2024 at 12:24 PM CEST Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2024 Download
Apr 15, 2024 at 10:08 AM CEST Transactions in Connection with Share Buy-back Program Genmab Download Download
Apr 08, 2024 at 11:44 AM CEST Transactions in Connection with Share Buy-back Program Download Download
Apr 03, 2024 at 7:34 AM CEST Genmab to Broaden and Strengthen Oncology Portfolio with Acquisition of ProfoundBio Download
Apr 02, 2024 at 9:24 AM CEST Transactions in Connection with Share Buy-back Program Download Download